Liang Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Liang Huang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Jian Liu
Emergency Department, The First Affiliated Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China
3 shared publicationsChunshui Cao
Emergency Department, The First Affiliated Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China
2 shared publicationsYang Li
Nanchang Univ, Dept Emergency Med, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China
2 shared publicationsYong Liu
Emergency Department, The First Affiliated Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China
2 shared publicationsChun-Shui Cao
Nanchang Univ, Dept Emergency Med, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China
1 shared publicationChunShui Cao
1 shared publication
Latest Publications
- 11 May 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Caffeic acid phenethyl ester attenuates phenotypic switching and inflammation in abdominal aortic aneurysm via the NF-κB pathway
In our previous animal experiments, we found that caffeic acid phenethyl ester (CAPE) inhibited the early formation of elastase-induced abdominal aortic aneurysms (AAA) in rats. However, its efficacy in the angiotensin II (Ang II)-induced AAA model and the underlying mechanism remain unclear. Therefore, the primary aim of this study was to further validate the potential mechanism of CAPE through in vivo and in vitro experiments utilizing Ang II. ApoE-/- mice were randomly divided into three groups: Sham group, Ang II model group, and Ang II + CAPE group. Mouse aortic smooth muscle cells (MOVAS) were pretreated with CAPE (0.25 and 0.5 µM) for 1 h or the NF-κB inhibitor BAY11-7082 (0.5 µM) for 0.5 h, followed by stimulation with Ang II (1 µM) for 24 h. In vivo, CAPE intervention significantly reduced the maximum diameter of the aorta, counteracted the increase in osteopontin (OPN) levels in AAA tissue, and restored the decrease in α-smooth muscle actin (α-SMA) expression observed in the model group. Moreover, serum levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were markedly decreased in the Ang II+CAPE group compared to the Ang II model group. In vitro, CAPE treatment significantly inhibited proliferation, migration, invasion and ROS production. It also reduced the apoptosis rate from 9.24 ± 0.60% to 6.11 ± 0.85% (0.25µM CAPE) and 6.00 ± 0.32% (0.5µM CAPE), accompanied by a decreased BAX/BCL-2 ratio. Furthermore, CAPE suppressed the expression of matrix metalloproteinases (MMPs), and OPN, suppressed activation of the NF-κB pathway, and restored α-SMA levels. CAPE mitigates the progression of AAA in mice and counteract the abnormal cell phenotype and inflammatory responses in Ang II-stimulated MOVAS cells. These protective effects might be achieved by inhibiting the NF-κB pathway.
- 11 May 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Caffeic acid phenethyl ester attenuates phenotypic switching and inflammation in abdominal aortic aneurysm via the NF-κB pathway
In our previous animal experiments, we found that caffeic acid phenethyl ester (CAPE) inhibited the early formation of elastase-induced abdominal aortic aneurysms (AAA) in rats. However, its efficacy in the angiotensin II (Ang II)-induced AAA model and the underlying mechanism remain unclear. Therefore, the primary aim of this study was to further validate the potential mechanism of CAPE through in vivo and in vitro experiments utilizing Ang II. ApoE-/- mice were randomly divided into three groups: Sham group, Ang II model group, and Ang II + CAPE group. Mouse aortic smooth muscle cells (MOVAS) were pretreated with CAPE (0.25 and 0.5 µM) for 1 h or the NF-κB inhibitor BAY11-7082 (0.5 µM) for 0.5 h, followed by stimulation with Ang II (1 µM) for 24 h. In vivo, CAPE intervention significantly reduced the maximum diameter of the aorta, counteracted the increase in osteopontin (OPN) levels in AAA tissue, and restored the decrease in α-smooth muscle actin (α-SMA) expression observed in the model group. Moreover, serum levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were markedly decreased in the Ang II+CAPE group compared to the Ang II model group. In vitro, CAPE treatment significantly inhibited proliferation, migration, invasion and ROS production. It also reduced the apoptosis rate from 9.24 ± 0.60% to 6.11 ± 0.85% (0.25µM CAPE) and 6.00 ± 0.32% (0.5µM CAPE), accompanied by a decreased BAX/BCL-2 ratio. Furthermore, CAPE suppressed the expression of matrix metalloproteinases (MMPs), and OPN, suppressed activation of the NF-κB pathway, and restored α-SMA levels. CAPE mitigates the progression of AAA in mice and counteract the abnormal cell phenotype and inflammatory responses in Ang II-stimulated MOVAS cells. These protective effects might be achieved by inhibiting the NF-κB pathway.
- 30 December 2023
- Published by Elsevier in Experimental Cell Research
- Vol. 435 (1) , 113905
SP1-stimulated miR-208a-5p aggravates sepsis-induced myocardial injury via targeting XIAP
- 30 December 2023
- Published by Elsevier in Experimental Cell Research
- Vol. 435 (1) , 113905
SP1-stimulated miR-208a-5p aggravates sepsis-induced myocardial injury via targeting XIAP
- 25 December 2023
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 65 (6) , 964-972
The role of red blood cell distribution width (RDW) in the diagnosis of pediatric sepsis
Background. Early diagnosis of pediatric sepsis is difficult, so it is necessary to find a reliable auxiliary diagnostic method. The purpose of the study was to assess the role of RDW in the diagnosis of pediatric sepsis.Methods. We did a case control study reviewing pediatric inpatients (>= 28 days, <18 years old) who were diagnosed with sepsis between April 2020 and November 2022. According to the sepsis-3 and Pediatric Sequential Organ Failure Assessment (pSOFA) scoring standards, 66 septic inpatients of the pediatric intensive care unit (PICU) were included in the sepsis group and 66 non-septic inpatients of the PICU were included by using the random sampling method during the same period as the control group.Results. RDW values in the sepsis group were higher than those in the control group (P<0.001). The cut-off value, sensitivity, specificity and area under curve of RDW for sepsis were 39.15, 0.955, 0.758 and 0.943,respectively.Conclusions. Our study confirms that RDW may have a good value on the early diagnosis of pediatric sepsis.
- 25 December 2023
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 65 (6) , 964-972
The role of red blood cell distribution width (RDW) in the diagnosis of pediatric sepsis
Background. Early diagnosis of pediatric sepsis is difficult, so it is necessary to find a reliable auxiliary diagnostic method. The purpose of the study was to assess the role of RDW in the diagnosis of pediatric sepsis.Methods. We did a case control study reviewing pediatric inpatients (>= 28 days, <18 years old) who were diagnosed with sepsis between April 2020 and November 2022. According to the sepsis-3 and Pediatric Sequential Organ Failure Assessment (pSOFA) scoring standards, 66 septic inpatients of the pediatric intensive care unit (PICU) were included in the sepsis group and 66 non-septic inpatients of the PICU were included by using the random sampling method during the same period as the control group.Results. RDW values in the sepsis group were higher than those in the control group (P<0.001). The cut-off value, sensitivity, specificity and area under curve of RDW for sepsis were 39.15, 0.955, 0.758 and 0.943,respectively.Conclusions. Our study confirms that RDW may have a good value on the early diagnosis of pediatric sepsis.
- Open Access
- 25 November 2023
- Published by Impact Journals, LLC in Aging
- Vol. 15 (22) , 13434-13451
Predicting the prognosis in patients with sepsis by an endoplasmic reticulum stress gene signature
Background: Prognostic stratification of patients with sepsis is important for the development of individualized treatment strategies. Endoplasmic reticulum stress (ERS) plays a key role in sepsis. This study aimed to identify a set of genes related to ER stress to construct a predictive model for the prognosis of sepsis. Methods: The transcriptomic and clinical data of 479 sepsis patients were obtained from GSE65682 and divided into a training set (n=288) and a validation set (n=191) at a ratio of 3:2. The external test set was GSE95233 (n=51). LASSO and Cox regression analyses were performed to establish a signature to predict the prognosis of patients with sepsis. Moreover, we developed a nomogram that included the risk signature and clinical features to predict survival probability. Results: A prognostic signature was constructed with ten endoplasmic reticulum related genes (ADRB2, DHCR7, GABARAPL2, MAOA, MPO, PDZD8, QDPR, SCAP, TFRC, and TLR4) in the training set, which significantly divided patients with sepsis into high- and low-risk groups in terms of survival. This signature was validated using validation and external test sets. A nomogram based on the risk signature was constructed to quantitatively predict the prognosis of patients with sepsis. Conclusions: We constructed an ERS signature as a novel prognostic marker for predicting survival in sepsis patients, which could be used to develop novel biomarkers for the diagnosis, treatment, and prognosis of sepsis and to provide new ideas and prospects for future clinical research.
- 25 November 2023
- Published by Impact Journals, LLC in Aging
- Vol. 15 (22) , 13434-13451
Open AccessPredicting the prognosis in patients with sepsis by an endoplasmic reticulum stress gene signature
Background: Prognostic stratification of patients with sepsis is important for the development of individualized treatment strategies. Endoplasmic reticulum stress (ERS) plays a key role in sepsis. This study aimed to identify a set of genes related to ER stress to construct a predictive model for the prognosis of sepsis. Methods: The transcriptomic and clinical data of 479 sepsis patients were obtained from GSE65682 and divided into a training set (n=288) and a validation set (n=191) at a ratio of 3:2. The external test set was GSE95233 (n=51). LASSO and Cox regression analyses were performed to establish a signature to predict the prognosis of patients with sepsis. Moreover, we developed a nomogram that included the risk signature and clinical features to predict survival probability. Results: A prognostic signature was constructed with ten endoplasmic reticulum related genes (ADRB2, DHCR7, GABARAPL2, MAOA, MPO, PDZD8, QDPR, SCAP, TFRC, and TLR4) in the training set, which significantly divided patients with sepsis into high- and low-risk groups in terms of survival. This signature was validated using validation and external test sets. A nomogram based on the risk signature was constructed to quantitatively predict the prognosis of patients with sepsis. Conclusions: We constructed an ERS signature as a novel prognostic marker for predicting survival in sepsis patients, which could be used to develop novel biomarkers for the diagnosis, treatment, and prognosis of sepsis and to provide new ideas and prospects for future clinical research.
- 1 January 2022
- Published by World Journal of Emergency Medicine in World Journal of Emergency Medicine
- Vol. 13 (4) , 337-340
The successful use of extracorporeal membrane oxygenation combined with continuous renal replacement therapy for a cardiac arrest patient with refractory hypokalemia and diabetic ketoacidosis
- 1 January 2022
- Published by World Journal of Emergency Medicine in World Journal of Emergency Medicine
- Vol. 13 (4) , 337-340
The successful use of extracorporeal membrane oxygenation combined with continuous renal replacement therapy for a cardiac arrest patient with refractory hypokalemia and diabetic ketoacidosis
- Open Access
- 11 June 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (23) , e26318
Successful treatment of severe myocardial injury complicated with refractory cardiogenic shock caused by AOPP using extracorporeal membrane oxygenation
Rationale: Acute organophosphorus pesticide poisoning (AOPP) is a common critical illness observed in clinical practice, and severe AOPP can cause serious cardiac toxicity. Patient concerns: This patient was a 43-year-old woman who was admitted to the emergency department with acute respiratory failure and hypotension 13 hours after oral consumption of 300 mL of phoxim pesticide. Diagnoses: Acute organophosphorus pesticide poisoning, cardiogenic shock. Interventions: We conducted veno-arterial extracorporeal membrane oxygenation (VA-ECMO) therapy as the patient did not respond to conventional measures. Outcomes: This patient was successfully rescued with VA-ECMO therapy and discharged. Lessons: We suggest that for patients with severe myocardial injury complicated with cardiogenic shock caused by AOPP, the use of VA-ECMO therapy can improve the prognosis.
- 11 June 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (23) , e26318
Open AccessSuccessful treatment of severe myocardial injury complicated with refractory cardiogenic shock caused by AOPP using extracorporeal membrane oxygenation
Rationale: Acute organophosphorus pesticide poisoning (AOPP) is a common critical illness observed in clinical practice, and severe AOPP can cause serious cardiac toxicity. Patient concerns: This patient was a 43-year-old woman who was admitted to the emergency department with acute respiratory failure and hypotension 13 hours after oral consumption of 300 mL of phoxim pesticide. Diagnoses: Acute organophosphorus pesticide poisoning, cardiogenic shock. Interventions: We conducted veno-arterial extracorporeal membrane oxygenation (VA-ECMO) therapy as the patient did not respond to conventional measures. Outcomes: This patient was successfully rescued with VA-ECMO therapy and discharged. Lessons: We suggest that for patients with severe myocardial injury complicated with cardiogenic shock caused by AOPP, the use of VA-ECMO therapy can improve the prognosis.
- Open Access
- 16 February 2021
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8
A Simple-to-Use Web-Based Calculator for Survival Prediction in Acute Respiratory Distress Syndrome
Background: The aim of this study was to construct and validate a simple-to-use model to predict the survival of patients with acute respiratory distress syndrome.Methods: A total of 197 patients with acute respiratory distress syndrome were selected from the Dryad Digital Repository. All eligible individuals were randomly stratified into the training set (n=133) and the validation set (n=64) as 2: 1 ratio. LASSO regression analysis was used to select the optimal predictors, and receiver operating characteristic and calibration curves were used to evaluate accuracy and discrimination of the model. Clinical usefulness of the model was also assessed using decision curve analysis and Kaplan-Meier analysis.Results: Age, albumin, platelet count, PaO2/FiO2, lactate dehydrogenase, high-resolution computed tomography score, and etiology were identified as independent prognostic factors based on LASSO regression analysis; these factors were integrated for the construction of the nomogram. Results of calibration plots, decision curve analysis, and receiver operating characteristic analysis showed that this model has good predictive ability of patient survival in acute respiratory distress syndrome. Moreover, a significant difference in the 28-day survival was shown between the patients stratified into different risk groups (P < 0.001). For convenient application, we also established a web-based calculator (https://huangl.shinyapps.io/ARDSprognosis/).Conclusions: We satisfactorily constructed a simple-to-use model based on seven relevant factors to predict survival and prognosis of patients with acute respiratory distress syndrome. This model can aid personalized treatment and clinical decision-making.
- 16 February 2021
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8
Open AccessA Simple-to-Use Web-Based Calculator for Survival Prediction in Acute Respiratory Distress Syndrome
Background: The aim of this study was to construct and validate a simple-to-use model to predict the survival of patients with acute respiratory distress syndrome.Methods: A total of 197 patients with acute respiratory distress syndrome were selected from the Dryad Digital Repository. All eligible individuals were randomly stratified into the training set (n=133) and the validation set (n=64) as 2: 1 ratio. LASSO regression analysis was used to select the optimal predictors, and receiver operating characteristic and calibration curves were used to evaluate accuracy and discrimination of the model. Clinical usefulness of the model was also assessed using decision curve analysis and Kaplan-Meier analysis.Results: Age, albumin, platelet count, PaO2/FiO2, lactate dehydrogenase, high-resolution computed tomography score, and etiology were identified as independent prognostic factors based on LASSO regression analysis; these factors were integrated for the construction of the nomogram. Results of calibration plots, decision curve analysis, and receiver operating characteristic analysis showed that this model has good predictive ability of patient survival in acute respiratory distress syndrome. Moreover, a significant difference in the 28-day survival was shown between the patients stratified into different risk groups (P < 0.001). For convenient application, we also established a web-based calculator (https://huangl.shinyapps.io/ARDSprognosis/).Conclusions: We satisfactorily constructed a simple-to-use model based on seven relevant factors to predict survival and prognosis of patients with acute respiratory distress syndrome. This model can aid personalized treatment and clinical decision-making.
- 1 January 2013
- Published by World Journal of Emergency Medicine in World Journal of Emergency Medicine
- Vol. 4 (4) , 266-272
Active compression-decompression cardiopulmonary resuscitation (CPR) versus standard CPR for cardiac arrest patients: a meta-analysis
BACKGROUND: Active compression-decompression cardiopulmonary resuscitation (ACDCPR) has been popular in the treatment of patients with cardiac arrest (CA). However, the effect of ACD-CPR versus conventional standard CPR (S-CRP) is contriversial. This study was to analyze the efficacy and safety of ACD-CPR versus S-CRP in treating CA patients. METHODS: Randomized or quasi-randomized controlled trials published from January 1990 to March 2011 were searched with the phrase "active compression-decompression cardiopulmonary resuscitation and cardiac arrest" in PubMed, EmBASE, and China Biomedical Document Databases. The Cochrane Library was searched for papers of meta-analysis. Restoration of spontaneous circulation (ROSC) rate, survival rate to hospital admission, survival rate at 24 hours, and survival rate to hospital discharge were considered primary outcomes, and complications after CPR were viewed as secondary outcomes. Included studies were critically appraised and estimates of effects were calculated according to the model of fixed or random effects. Inconsistency across the studies was evaluated using the I 2 statistic method. Sensitivity analysis was made to determine statistical heterogeneity. RESULTS: Thirteen studies met the criteria for this meta-analysis. The studies included 396 adult CA patients treated by ACD-CPR and 391 patients by S-CRP. Totally 234 CA patients were found out hospitals, while the other 333 CA patients were in hospitals. Two studies were evaluated with high-quality methodology and the rest 11 studies were of poor quality. ROSC rate, survival rate at 24 hours and survival rate to hospital discharge with favorable neurological function indicated that ACD-CPR is superior to S-CRP, with relative risk (RR) values of 1.39 (95% CI 0.99-1.97), 1.94 (95% CI 1.45-2.59) and 2.80 (95% CI 1.60-5.24). No significant differences were found in survival rate to hospital admission and survival rate to hospital discharge for ACD-CPR versus S-CRP with RR values of 1.06 (95% CI 0.76-1.60) and 1.00 (95% CI 0.73-1.38). CONCLUSION: Quality controlled studies confirmed the superiority of ACD-CPR to S-CRP in terms of ROSC rate and survival rate at 24 hours. Compared with S-CRP, ACD-CPR could not improve survival rate to hospital admission or survival rate to hospital discharge.
- 1 January 2013
- Published by World Journal of Emergency Medicine in World Journal of Emergency Medicine
- Vol. 4 (4) , 266-272
Active compression-decompression cardiopulmonary resuscitation (CPR) versus standard CPR for cardiac arrest patients: a meta-analysis
BACKGROUND: Active compression-decompression cardiopulmonary resuscitation (ACDCPR) has been popular in the treatment of patients with cardiac arrest (CA). However, the effect of ACD-CPR versus conventional standard CPR (S-CRP) is contriversial. This study was to analyze the efficacy and safety of ACD-CPR versus S-CRP in treating CA patients. METHODS: Randomized or quasi-randomized controlled trials published from January 1990 to March 2011 were searched with the phrase "active compression-decompression cardiopulmonary resuscitation and cardiac arrest" in PubMed, EmBASE, and China Biomedical Document Databases. The Cochrane Library was searched for papers of meta-analysis. Restoration of spontaneous circulation (ROSC) rate, survival rate to hospital admission, survival rate at 24 hours, and survival rate to hospital discharge were considered primary outcomes, and complications after CPR were viewed as secondary outcomes. Included studies were critically appraised and estimates of effects were calculated according to the model of fixed or random effects. Inconsistency across the studies was evaluated using the I 2 statistic method. Sensitivity analysis was made to determine statistical heterogeneity. RESULTS: Thirteen studies met the criteria for this meta-analysis. The studies included 396 adult CA patients treated by ACD-CPR and 391 patients by S-CRP. Totally 234 CA patients were found out hospitals, while the other 333 CA patients were in hospitals. Two studies were evaluated with high-quality methodology and the rest 11 studies were of poor quality. ROSC rate, survival rate at 24 hours and survival rate to hospital discharge with favorable neurological function indicated that ACD-CPR is superior to S-CRP, with relative risk (RR) values of 1.39 (95% CI 0.99-1.97), 1.94 (95% CI 1.45-2.59) and 2.80 (95% CI 1.60-5.24). No significant differences were found in survival rate to hospital admission and survival rate to hospital discharge for ACD-CPR versus S-CRP with RR values of 1.06 (95% CI 0.76-1.60) and 1.00 (95% CI 0.73-1.38). CONCLUSION: Quality controlled studies confirmed the superiority of ACD-CPR to S-CRP in terms of ROSC rate and survival rate at 24 hours. Compared with S-CRP, ACD-CPR could not improve survival rate to hospital admission or survival rate to hospital discharge.